| | | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FDA Comment Number :
|
| EREG7
|
|
|
|
|
| Submitter :
|
| Mr. Billy Valentine
|
| Date & Time:
|
| 09/26/2005 05:09:18
|
|
|
|
|
| Organization :
|
| Franciscan University College Republicans
|
|
|
|
|
| Category :
|
| Drug Association
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| The morning after pill should not be allowed over-the-counter in any circumstance, not even with age restrictions.
|
|
|
|
|
|
|
|
|
|
|